These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 19641362)

  • 1. Effects of tamsulosin on lower urinary tract symptoms due to double-J stent: a prospective study.
    Wang CJ; Huang SW; Chang CH
    Urol Int; 2009; 83(1):66-9. PubMed ID: 19641362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of terazosin on lower urinary tract symptoms and pain due to double-J stent: a double-blind placebo-controlled randomized clinical trial.
    Mokhtari G; Shakiba M; Ghodsi S; Farzan A; Heidari Nejad S; Esmaeili S
    Urol Int; 2011; 87(1):19-22. PubMed ID: 21597261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a role for alpha1-blockers in treating double-J stent-related symptoms?
    Deliveliotis C; Chrisofos M; Gougousis E; Papatsoris A; Dellis A; Varkarakis IM
    Urology; 2006 Jan; 67(1):35-9. PubMed ID: 16413328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
    Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
    BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
    Nishino Y; Masue T; Miwa K; Takahashi Y; Ishihara S; Deguchi T
    BJU Int; 2006 Apr; 97(4):747-51, discussion 751. PubMed ID: 16536766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.
    Roehrborn CG; Kaplan SA; Kraus SR; Wang JT; Bavendam T; Guan Z
    Urology; 2008 Nov; 72(5):1061-7; discussion 1067. PubMed ID: 18817961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of specific alpha-1A/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized study.
    Wang CJ; Huang SW; Chang CH
    Urol Res; 2009 Jun; 37(3):147-52. PubMed ID: 19277623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.
    Roehrborn CG; Kaplan SA; Jones JS; Wang JT; Bavendam T; Guan Z
    Eur Urol; 2009 Feb; 55(2):472-9. PubMed ID: 18583022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of tamsulosin in the management of lower ureteral stones: a randomized double-blind placebo-controlled study of 100 patients.
    Al-Ansari A; Al-Naimi A; Alobaidy A; Assadiq K; Azmi MD; Shokeir AA
    Urology; 2010 Jan; 75(1):4-7. PubMed ID: 20109697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stent positioning after ureteroscopy for urinary calculi: the question is still open.
    Damiano R; Autorino R; Esposito C; Cantiello F; Sacco R; de Sio M; D'Armiento M
    Eur Urol; 2004 Sep; 46(3):381-7; discussion 387-8. PubMed ID: 15306112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent tamsulosin therapy in men with lower urinary tract symptoms.
    Yanardag H; Goktas S; Kibar Y; Kilic S; Erduran D
    J Urol; 2005 Jan; 173(1):155-7. PubMed ID: 15592062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic tamsulosin (Flomax) in patients undergoing prostate 125I brachytherapy for prostate carcinoma: final report of a double-blind placebo-controlled randomized study.
    Elshaikh MA; Ulchaker JC; Reddy CA; Angermeier KW; Klein EA; Chehade N; Altman A; Ciezki JP
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):164-9. PubMed ID: 15850917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomized evaluation of periureteral botulinum toxin type A injection for ureteral stent pain reduction.
    Gupta M; Patel T; Xavier K; Maruffo F; Lehman D; Walsh R; Landman J
    J Urol; 2010 Feb; 183(2):598-602. PubMed ID: 20018320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of tamsulosin hydrochloride in relieving "double-J ureteral stent-related morbidity": a randomized placebo controlled clinical study.
    Singh I; Tripathy S; Agrawal V
    Int Urol Nephrol; 2014 Dec; 46(12):2279-83. PubMed ID: 25201459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tamsulosin in preventing ureteral stent-related morbidity: a prospective study.
    Damiano R; Autorino R; De Sio M; Giacobbe A; Palumbo IM; D'Armiento M
    J Endourol; 2008 Apr; 22(4):651-6. PubMed ID: 18338955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of doxazosin gastrointestinal therapeutic system 4 mg vs tamsulosin 0.2 mg on nocturia in Chinese men with lower urinary tract symptoms: a prospective, multicenter, randomized, open, parallel study.
    Zhang K; Yu W; Jin J; Ye H; Wang X; Zhang N; Yang Y; Zhong C; Wan B
    Urology; 2011 Sep; 78(3):636-40. PubMed ID: 21696807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of terazosin and tolterodine on ureteral stent related symptoms: a double-blind placebo-controlled randomized clinical trial.
    Tehranchi A; Rezaei Y; Khalkhali H; Rezaei M
    Int Braz J Urol; 2013; 39(6):832-40. PubMed ID: 24456787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of efficacy and tolerance of short-duration open-ended ureteral catheter drainage and tamsulosin administration to indwelling double J stents following ureteroscopic removal of stones.
    Chauhan VS; Bansal R; Ahuja M
    Hong Kong Med J; 2015 Apr; 21(2):124-30. PubMed ID: 25756274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study.
    Beddingfield R; Pedro RN; Hinck B; Kreidberg C; Feia K; Monga M
    J Urol; 2009 Jan; 181(1):170-6. PubMed ID: 19013590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ureteral stents: morbidity and impact on quality of life.
    Leibovici D; Cooper A; Lindner A; Ostrowsky R; Kleinmann J; Velikanov S; Cipele H; Goren E; Siegel YI
    Isr Med Assoc J; 2005 Aug; 7(8):491-4. PubMed ID: 16106772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.